Minister wants to phase out funding for long COVID centers: ‘They must not give up on the patients’

Long-COVID or post-COVID care centers support people whose health problems continue after a SARS-CoV-2 infection. They matter because persistent symptoms may affect several parts of daily life and may require coordinated care. The source identifies specialist centers, but it does not give a full service list.

In established practice, such centers may assess symptoms, coordinate medical specialists, offer rehabilitation, and help patients manage activity, work, and daily routines. A patient might therefore receive an assessment from one team and referrals to physiotherapy, occupational therapy, or psychological support. Exact services differ by center and country.

The source presents these centers as relatively new and says their continued existence is already threatened. It also reports calls for conditions to be established before post-COVID care is changed. This matters because specialist expertise may disappear if funding ends before regular services can provide coordinated, suitable care.

Minister Hermans is associated with a proposal to reduce or phase out government financing for long-COVID centers. This matters because the centers depend on public funding to maintain specialist teams and coordinated support. The source does not provide the proposed budget, a precise timetable, or a final decision.

The clearest timing clue is the headline saying Hermans could prepare apologies to post-COVID patients by 2040. That wording signals a long-term concern about what happens if specialist care is withdrawn. It should not be read as a detailed confirmation that funding ends exactly in 2040.

The source also includes a call to establish conditions for post-COVID care first. That suggests the funding change is being discussed alongside questions about responsibility, access, and service standards. Until those details are settled, patients and providers cannot know exactly when centers would lose support or what would replace them.

The source does not state how many people develop long COVID. It also does not say how many patients depend on specialist centers. Those figures cannot be calculated from the supplied headlines, so a precise answer would risk inventing evidence.

In general, researchers report that the share varies according to the definition used, the population studied, vaccination status, and the period examined. Patient numbers at specialist centers also depend on referral rules, capacity, and whether people receive care elsewhere. These factors make one universal figure unsuitable without a named study.

What the source does establish is the policy concern. Specialist centers exist, their funding may be reduced, and their future is contested. Reliable scale figures would be important for that debate because they would show how many people could be affected. The supplied source, however, provides no such measurements.

The government’s reported direction is to reduce or end special funding for long-COVID centers. The source does not explicitly explain the government’s full reasoning. A likely policy goal is to place care within ordinary healthcare rather than maintain separate, temporary centers, but that interpretation comes from general health-policy practice, not a stated reason here.

The source does clearly mention a demand for “first conditions” for post-COVID care. In practical terms, such conditions could concern available expertise, referral routes, cooperation between providers, and access for patients. However, the supplied text does not identify the proposed conditions, so these examples should not be treated as confirmed details.

The central issue is sequence. Specialist funding may be reduced, while others argue that a workable care system must be secured beforehand. Without agreed arrangements, the change could create gaps between specialist centers and routine healthcare. The source gives no final decision or implementation plan.

If centers lose funding before other services are ready, patients could face fewer specialist appointments, longer waits, or confusing referrals. Care might become fragmented if no provider has responsibility for symptoms that cross medical specialties. The source captures this concern in the warning that patients must not be given up on.

For example, a patient receiving coordinated help at a center might instead need separate appointments with a general practitioner, hospital department, and rehabilitation provider. If those services do not share expertise or information, the patient may repeat their story and still lack a clear plan. This is a general risk of replacing a coordinated service without an operational alternative.

The source does not document actual closures, waiting times, or confirmed patient outcomes. It does show that the centers are only recently active while their future funding is already questioned. That timing makes the transition important: regular services would need capacity and clear arrangements before specialist support is withdrawn.

General practitioners, hospitals, rehabilitation services, and other providers could potentially absorb parts of long-COVID care. Whether they can replace specialist centers depends on staffing, knowledge, referral pathways, and time for complex patients. The source does not confirm that these services are currently ready to take over.

A possible model would give general practitioners an entry point, hospitals access to specialist assessment, and rehabilitation services support with recovery and daily functioning. The key mechanism is coordination: one provider must help connect the different parts of care. Without that link, patients may be passed between services rather than treated as a whole person.

The source’s call for “first conditions” points to this practical challenge. It supports preparing the wider care system before special funding is reduced. The articles do not say which providers would assume responsibility, how much funding they would receive, or whether a formal handover plan exists.

Long COVID, also called post-COVID, describes ongoing or newly appearing symptoms after an acute SARS-CoV-2 infection. Symptoms can involve energy, breathing, thinking, sleep, pain, or other body systems. It matters because recovery is not always quick and some people need continuing medical or rehabilitation support. These details come from established medical knowledge, not the supplied headlines.

Scientists think several mechanisms may contribute. They include persistent immune activation, disturbances in the nervous or circulatory systems, changes after organ injury, and possibly remnants of viral material. Different people may have different mechanisms, and no single explanation covers every case. A continuing symptom does not necessarily mean that live virus remains in the body.

The source gives no biological explanation. It focuses on the policy dispute over specialist centers and funding, including whether care should continue separately or move into regular services. That debate matters because patients with long-lasting symptoms still need appropriate assessment and support while research continues.